Point72 (Difc) LTD Immuneering Corp Transaction History
Point72 (Difc) LTD
- $2.72 Trillion
- Q4 2024
A detailed history of Point72 (Difc) LTD transactions in Immuneering Corp stock. As of the latest transaction made, Point72 (Difc) LTD holds 16 shares of IMRX stock, worth $24. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16
Previous 16
-0.0%
Holding current value
$24
Previous $40,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IMRX
# of Institutions
44Shares Held
4.59MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.06MShares$1.61 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD767KShares$1.17 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$810,7130.0% of portfolio
-
Morgan Stanley New York, NY454KShares$690,2320.0% of portfolio
-
Southport Management, L.L.C. Wilson, WY215KShares$326,8001.71% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $40.1M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...